UBS Maintains Neutral on Exponent, Lowers Price Target to $72

Exponent, Inc.

Exponent, Inc.

EXPO

0.00

UBS analyst Joshua Chan maintains Exponent (NASDAQ: EXPO) with a Neutral and lowers the price target from $75 to $72.